Company intelligence / Profile preview

Xenopharm

Cheongju-si, Chungcheongbuk-do, South Korea
Ownership
Private
Development stage
Other
01

Overview

Xenopharm is a South Korean biotechnology company specializing in animal health, diagnostics, and advanced research in xenotransplantation. The company develops and manufactures a variety of rapid diagnostic kits for critical livestock diseases, such as Foot and Mouth Disease (FMD) and Porcine Reproductive and Respiratory Syndrome (PRRS). In addition to its diagnostic portfolio, Xenopharm is involved in the development of animal vaccines and bio-materials. A core focus of its long-term research is xenotransplantation, where it utilizes transgenic pig models to develop organs and tissues suitable for human transplantation. Xenopharm aims to improve global health outcomes by advancing the fields of veterinary diagnostics and regenerative medicine.

Therapeutic areas
NephrologyInfectious Diseases
Modalities
VaccineDiagnostic kitCell therapy
Industry
Biotech
02

Partnerships

Chungbuk National University

Beyond the preview

Go deeper on Xenopharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xenopharm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call